Cegedim Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Cegedim ha aumentado sus beneficios a una tasa media anual de 14.8%, mientras que los beneficios de la industria de Healthcare Services han experimentado un crecimiento anual de 2.2%. Los ingresos han ido creciendo a una tasa media de 4.8% al año.

Información clave

14.8%

Tasa de crecimiento de los beneficios

14.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare Services	21.0%
Tasa de crecimiento de los ingresos	4.8%
Rentabilidad financiera	-2.5%
Margen neto	-1.2%
Próxima actualización de resultados	26 Sep 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 06

Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years

Nov 23

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Cegedim. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ENXTPA:CGM Ingresos, gastos y beneficios (EUR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	616	-7	141
30 Sep 23	602	1	136
30 Jun 23	589	10	131
31 Mar 23	572	12	126
31 Dec 22	555	14	121
30 Sep 22	548	14	119
30 Jun 22	541	15	116
31 Mar 22	533	21	112
31 Dec 21	525	26	108
30 Sep 21	518	24	103
30 Jun 21	512	22	98
31 Mar 21	504	16	100
31 Dec 20	497	11	102
30 Sep 20	496	10	108
30 Jun 20	494	8	114
31 Mar 20	499	5	115
31 Dec 19	504	3	116
30 Sep 19	495	-1	119
30 Jun 19	486	-5	121
31 Mar 19	477	0	123
31 Dec 18	468	4	124
30 Sep 18	464	8	120
30 Jun 18	461	12	116
31 Mar 18	459	10	119
31 Dec 17	457	7	122
30 Sep 17	452	-13	123
30 Jun 17	438	-17	125
31 Mar 17	435	-12	125
31 Dec 16	429	-29	123
30 Sep 16	438	13	121
30 Jun 16	435	9	120
31 Mar 16	432	1	113
31 Dec 15	426	19	109
30 Sep 15	364	0	102
30 Jun 15	380	-6	103
31 Mar 15	399	-4	107
31 Dec 14	412	-8	111
30 Sep 14	161	-26	46
30 Jun 14	266	-11	71
31 Mar 14	377	-5	99
31 Dec 13	488	-14	124
30 Sep 13	906	21	232
30 Jun 13	904	4	234

Ingresos de calidad: CGM actualmente no es rentable.

Margen de beneficios creciente: CGM actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: CGM no es rentable, pero ha reducido pérdidas en los últimos 5 años a un ritmo de 14.8% por año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de CGM en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: CGM no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare Services (11.7%).

Rentabilidad financiera

Alta ROE: CGM tiene una rentabilidad financiera negativa (-2.51%), ya que actualmente no es rentable.

Cegedim Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Third quarter 2023 earnings released: EPS: €0.051 (vs €0.68 in 3Q 2022)

Cegedim SA to Report First Half, 2024 Results on Sep 26, 2024

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

Full year 2022 earnings: EPS exceeds analyst expectations

Cegedim SA to Report First Half, 2023 Results on Sep 20, 2023

Recent updates

Price target decreased by 7.9% to €19.37

New major risk - Financial position

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings released: EPS: €0.051 (vs €0.68 in 3Q 2022)

Getting In Cheap On Cegedim SA (EPA:CGM) Might Be Difficult

Consensus EPS estimates fall by 18%

Cegedim SA to Report First Half, 2024 Results on Sep 26, 2024

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

Cegedim Provides Revenue Guidance for the Full Year 2023

First half 2023 earnings released: €0.64 loss per share (vs €0.36 loss in 1H 2022)

New minor risk - Earnings quality

Cegedim SA Provides Revenue Guidance for the Full Year 2023

These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively

Consensus EPS estimates increase by 16%

When Should You Buy Cegedim SA (EPA:CGM)?

Full year 2022 earnings: EPS exceeds analyst expectations

Price target increased by 7.1% to €21.40

Cegedim SA Provides Group Revenue Guidance for the Year 2023

Less than half of directors are independent

Cegedim SA to Report First Half, 2023 Results on Sep 20, 2023

Consensus forecasts updated

Cegedim SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Consensus forecasts updated

Cegedim Provides Revenue Guidance for 2022

These 4 Measures Indicate That Cegedim (EPA:CGM) Is Using Debt Extensively

First half 2022 earnings released: €0.40 loss per share (vs €0.47 profit in 1H 2021)

Cegedim SA (ENXTPA:CGM) acquired Merito, SAS.

Upcoming dividend of €0.50 per share

Price target decreased to €28.83

Less than half of directors are independent

Cegedim, Malakoff Humanis, Groupe VYV, PRO BTP in Talks for Acquisition of Equity Stake in Cegedim Santé

Is Now The Time To Put Cegedim (EPA:CGM) On Your Watchlist?

Investor sentiment improved over the past week

Cegedim SA Provides Revenue Guidance for the Year 2022

Cegedim SA to Report First Half, 2022 Results on Sep 20, 2022

Cegedim Provides Revenue Guidance for the Year 2021

First half 2021 earnings released: EPS €0.47 (vs €0.34 loss in 1H 2020)

Consensus forecasts updated

Is Cegedim SA (EPA:CGM) Trading At A 26% Discount?

Should You Think About Buying Cegedim SA (EPA:CGM) Now?

Consensus forecasts updated

Cegedim Provides Revenue Guidance for the Year 2021

Cegedim (EPA:CGM) Seems To Use Debt Quite Sensibly

Cegedim's (EPA:CGM) Shareholders Are Down 33% On Their Shares

Full year 2020 earnings released: EPS €0.78 (vs €0.20 in FY 2019)

Cegedim SA Provides Earnings Guidance for the Year 2021

Are Investors Undervaluing Cegedim SA (EPA:CGM) By 43%?

New 90-day low: €23.20

What Is Cegedim SA's (EPA:CGM) Share Price Doing?

Analysts update estimates

What Is The Ownership Structure Like For Cegedim SA (EPA:CGM)?

Cegedim SA (EPA:CGM) Delivered A Weaker ROE Than Its Industry

What Does Cegedim's (EPA:CGM) CEO Pay Reveal?

Does Cegedim's (EPA:CGM) Statutory Profit Adequately Reflect Its Underlying Profit?

Market bids up stock over the past week

New 90-day high: €27.50

Cegedim's (EPA:CGM) Stock Price Has Reduced 26% In The Past Three Years

New 90-day low: €22.30

Analysts lower EPS estimates to €0.88

Analysts lower EPS estimates to €1.21

New 90-day low: €23.50

New 90-day low - €26.40

Price target raised to €31.88

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Desglose de ingresos y gastos
Beta